Dr Laurence Morandeau
Dr Laurence Morandeau is the Chief R&D Radiochemist in the RAPID Laboratories at SCGH and is supervising the development and clinical routine production of the non-FDG PET and Molecular Radiotherapy Radiopharmaceuticals at SCGH. She obtained her PhD in Chemistry in France in 2001, working on the synthesis of bivalent haptens for applications to cancer radioimmunotherapy, followed by a post-doc in Fremantle Hospital and Murdoch University on the labelling of antibodies and peptides with Lutetium-177
Stay Connected.
Join your fellow Nuclear Medicine peers in ANZSNM social media channels
Conference Manager
For all conference enquires, please talk to the team at: Event Studio Group Pty Ltd 60 Wellington Square, North Adelaide SA 5006 +61 8 8379 8222 ANZSNM2021@eventstudio.com.au
Privacy
To view the privacy statement, click here